Amanta Healthcar

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
146.95
-1.3 (-0.88%)
BSENSE

Jun 18

BSE+NSE Vol: 51.72 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039743,
    "name": "Amanta Healthcar",
    "stock_name": "Amanta Healthcar",
    "full_name": "Amanta Healthcare Ltd",
    "name_url": "stocks-analysis/amanta-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "146.95",
    "chg": -1.3,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "148.25",
    "mcapval": "583.00 Cr",
    "mcap": "",
    "scripcode": 544502,
    "symbol": "AMANTA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE084K01015",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "51.72 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/amanta-healthcar-10039743-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039743",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/amanta-healthcare-10039743"
  },
  "announcements": [
    {
      "caption": "Intimation For Commissioning Of Solar Power Plant For Captive Consumption",
      "datetime": "30-May-2026",
      "details": "Intimation for commissioning of solar power plant for captive consumption",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year ended on March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation In Utilization Of Funds If Any.",
      "datetime": "29-May-2026",
      "details": "statement of deviation or variation of funds if any",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Intimation For Commissioning Of Solar Power Plant For Captive Consumption

30-May-2026 | Source : BSE

Intimation for commissioning of solar power plant for captive consumption

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the Financial Year ended on March 31 2026

Statement Of Deviation Or Variation In Utilization Of Funds If Any.

29-May-2026 | Source : BSE

statement of deviation or variation of funds if any

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available